Myeloma Drug, Hub Funding, Biotech Deals
Kilder
- STAT: STAT+: PBMs agree to display TrumpRx drug prices
- STAT: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class - STAT
- Indexbox: PBMs Partner with TrumpRx for Enhanced Prescription Drug Price Transparency - News and Statistics - IndexBox
- STAT: STAT+: PBMs agree to display TrumpRx drug prices
- STAT: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class - STAT
- Indexbox: PBMs Partner with TrumpRx for Enhanced Prescription Drug Price Transparency - News and Statistics - IndexBox
- BioPharma Dive: Biotech initiatives pick up as more regions race to become hubs
- Endpoints: MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta
- BioPharma Dive: Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
- Finance: Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers - Yahoo Finance
- Endpoints: Redx tries again at reverse merger, with Skye this time, as route gains steam
- wikimedia: Photo by Globetrotter19 / Wikimedia Commons / CC BY-SA 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.